Genzyme gets FDA nod for multiple sclerosis drug Lemtrada

November 16, 2014 9:43 AM

2 0

US health regulator Food and Drug administration (FDA) on Saturday approved sale of the multiple sclerosis (MS) curing drug Lemtrada, manufactured by biotech company Genzyme, in the country.

The FDA decision arrives 11 months after the health body had initially rejected the sale of the drug on several side effect concerns.

Read more

To category page